REQUEST A DEMO
Total
USD $0.00
Search more companies

Grupo Comercial Biotek S.A.S. (Colombia)

Main Activities: Lessors of Real Estate
Full name: Grupo Comercial Biotek S.A.S. Profile Updated: July 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Grupo Comercial Biotek S.A.S. is an enterprise located in Colombia, with the main office in Cali. The company operates in the Lessors of Real Estate sector. It was first established on October 27, 2016. There are currently 2 (2026) people employed by Grupo Comercial Biotek S.A.S.. From the latest financial highlights, Grupo Comercial Biotek S.A.S. reported a net sales revenue increase of 679.3% in 2025. There was a total negative growth of 12.67% in Grupo Comercial Biotek S.A.S.’s total assets over the same period. In 2025, Grupo Comercial Biotek S.A.S.’s net profit margin increased by 116.11%.

Headquarters
Calle 15 Norte # 6N-34 Oficina 402
Cali; Valle del Cauca;

Contact Details: Purchase the Grupo Comercial Biotek S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Grupo Comercial Biotek S.A.S. report to view the information.
Financial Auditors:
Purchase the Grupo Comercial Biotek S.A.S. report to view the information.
Incorporation Date:
October 27, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Grupo Comercial Biotek S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
679.3%
Total Operating Revenue
679.3%
Operating Profit
N/A
Net Profit/Loss for the Period
6357.62%
Total Assets
-12.67%
Total Equity
53.05%
Operating Profit Margin
N/A
Net Profit Margin
116.11%
Return on Equity (ROE)
33.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?